MPL and autoimmune thrombocytopenic purpura: They had a median of 2 unique prior lines of ITP therapy (range 1 to 6), including corticosteroids (prednisone and/or dexamethasone), intravenous immunoglobulin, splenectomy, rituximab, azathioprine, and thrombopoietin receptor agonists.